Search results for: OHE Consulting
Filter search results
Bridging the Gap: Pathways for Regulatory and Health Technology Assessment of Histology Independent Cancer Treatments
8 January 2021
…M., Henderson N., Steuten L., 2020. Bridging the Gap: Pathways for Regulatory and Health Technology Assessment of Histology Independent Medicines. OHE Consulting Report, London: Office of Health Economics. Available at: https://www.ohe.org/publications/bridging-gap-pathways-regulatory-and-health-technology-assessment-histology-independent…
Time to Tackle the Challenges around Combination Therapies for Cancer
29 March 2021
…individual components in a combination. A recent OHE/Amgen paper on this was described in an OHE blog, and a paper is expected soon from a Takeda sponsored group looking at…
Latest estimates show that 20 people a day die in unrelieved pain across the UK at the end of their lives
26 November 2024
…was unavoidable with current palliative care options. Source: Zamora, B., Cookson, G. and Garau, M., 2019. Unrelieved Pain in Palliative Care in England. OHE Consulting Report, London: Office of Health…
OHE at ISPOR May 2016: Meet the Team
19 May 2016
…Preliminary results were featured in a previous OHE blog. Poster: Important Aspects of (Full) Health Not Captured by EQ-5D OHE Authors: Koonal Shah Time and date: Wednesday 25th May, 8:30am…
MoCA Initiative and its Value Framework: An Opportunity to Improve Decision Making for Orphan Drugs in Europe?
18 September 2018
…product will reach the market at all. Towse, A. and Garau, M. (2018). Appraising Ultra-Orphan Drugs: Is Cost-Per-QALY Appropriate? A Review of the Evidence. OHE Consulting Report. RePEc Zamora, B.,…
Is Rate Of Return Pricing A Useful Approach When Value-Based Pricing Is Not Appropriate?
22 March 2019
…and Garau, M., 2018. Appraising Ultra-Orphan Drugs: Is Cost-Per-QALY Appropriate? A Review of the Evidence. OHE Consulting Report. RePEc. Pearson S., 2019. Early Experience with Health Technology Assessment of Gene Therapies…
NICE’s severity modifier: a step in the right direction, but still a long way to go
23 March 2022
…literature. Social Science & Medicine, 204, 39–50. Zhang, K., and Garau, M. 2020. International Cost-Effectiveness Thresholds and Modifiers for HTA Decision Making. OHE Consulting Report. Zhang, K., Kumar, G., &…
Exploring the Interdependency between Public and Charitable Medical Research
1 April 2011
Continuing concern about the fiscal deficit makes it likely that government funding of health and medical research will remain under scrutiny. This OHE Consulting study, commissioned by Cancer Research UK,…
Researching the Relative Efficacy and Relative Effectiveness of Medicines across Europe
1 October 2010
Ten member companies of the EFPIA HTA Task Force commissioned OHE consulting to provide research, data and analysis that would enable EFPIA both to support and develop its policy position…